Literature DB >> 16968888

Evidence that calcineurin is required for the genesis of bone-resorbing osteoclasts.

Li Sun1, Yuanzhen Peng, Neeha Zaidi, Ling-Ling Zhu, Jameel Iqbal, Kosj Yamoah, Xin Wang, Peng Liu, Etsuko Abe, Baljit S Moonga, Solomon Epstein, Mone Zaidi.   

Abstract

Here, we demonstrate that the Ca(2+)/calmodulin-sensitive phosphatase calcineurin is a necessary downstream mediator for osteoclast differentiation. Using quantitative PCR, we detected the calcineurin isoforms Aalpha, Abeta, Agamma (catalytic), and B1 (regulatory) in osteoclast precursor RAW-C3 cells. We found that, although the expression of these isoforms remained relatively unchanged during osteoclast differentiation, there was a profound increase in the expression of their primary substrate for calcineurin, nuclear factor of activated T cells (NFAT)c1. For gain-of-function studies, we incubated osteoclast precursors for 10 min with a calcineurin fusion protein (TAT-calcineurin Aalpha); this resulted in its receptorless influx into >90% of the precursor cells. A marked increase in the expression of the osteoclast differentiation markers tartrate-resistant acid phosphatase (TRAP) and integrin beta(3) followed. In addition, the expression of NFATc1, as well as the alternative substrate for calcineurin, IkappaBalpha, was significantly enhanced. Likewise, transfection with constitutively active NFAT resulted in an increased expression of both TRAP and integrin beta(3). In parallel loss-of-function studies, transfection with dominant-negative NFAT not only inhibited osteoclast formation but also reversed the induction of NFATc1, TRAP, and integrin beta(3) by TAT-calcineurin Aalpha. The expression of these markers was also inhibited by calcineurin Aalpha U1 small nuclear RNA, which significantly reduced calcineurin Aalpha mRNA and protein expression. Consistent with these observations, we observed a reduction in osteoclastogenesis in calcineurin Aalpha(-/-) cells and in osteoclast precursors treated with the calcineurin inhibitors cyclosporin A and FK506. Together, the gain- and loss-of-function experiments establish that calcineurin Aalpha is necessary for osteoclast formation from its precursor and that this occurs via an NFATc1-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16968888     DOI: 10.1152/ajprenal.00415.2005

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  19 in total

Review 1.  Osteoporosis after transplantation.

Authors:  Carolina A Moreira Kulak; Victoria Z Cochenski Borba; Jaime Kulak; Melani Ribeiro Custódio
Journal:  Curr Osteoporos Rep       Date:  2012-03       Impact factor: 5.096

2.  Specificity of RGS10A as a key component in the RANKL signaling mechanism for osteoclast differentiation.

Authors:  Shuying Yang; Wei Chen; Philip Stashenko; Yi-Ping Li
Journal:  J Cell Sci       Date:  2007-10-01       Impact factor: 5.285

3.  Is there a role for NFAT inhibitors in the prevention of bone destruction?

Authors:  Mark S McMahon
Journal:  HSS J       Date:  2009-05-16

Review 4.  Regulation of Skeletal Homeostasis.

Authors:  Mone Zaidi; Tony Yuen; Li Sun; Clifford J Rosen
Journal:  Endocr Rev       Date:  2018-10-01       Impact factor: 19.871

5.  FKBP12: A partner of Snx10 required for vesicular trafficking in osteoclasts.

Authors:  Ricardo A Battaglino; Prakash Jha; Farhath Sultana; Weimin Liu; Leslie R Morse
Journal:  J Cell Biochem       Date:  2019-03-19       Impact factor: 4.429

6.  Calcineurin promotes proliferation, migration, and invasion of small cell lung cancer.

Authors:  Yan Liu; Ye Zhang; Jie Min; Li-Li Liu; Ning-Qiang Ma; Ying-Ming Feng; Dong Liu; Ping-zhong Wang; De-Dong Huang; Yan Zhuang; He-Long Zhang
Journal:  Tumour Biol       Date:  2010-04-27

Review 7.  Transcriptional regulation of bone and joint remodeling by NFAT.

Authors:  Despina Sitara; Antonios O Aliprantis
Journal:  Immunol Rev       Date:  2010-01       Impact factor: 12.988

8.  Effects of bisphosphonate treatment on bone repair under immunosuppression using cyclosporine A in adult rats.

Authors:  T Matsunaga; M Shigetomi; T Hashimoto; H Suzuki; T Gondo; H Tanaka; T Sugiyama; T Taguchi
Journal:  Osteoporos Int       Date:  2007-05-10       Impact factor: 4.507

9.  The Role of Methionine Oxidation/Reduction in the Regulation of Immune Response.

Authors:  Abdulbaki Agbas; Jackob Moskovitz
Journal:  Curr Signal Transduct Ther       Date:  2009-01-01

10.  Dexamethasone increases αvβ3 integrin expression and affinity through a calcineurin/NFAT pathway.

Authors:  Jennifer A Faralli; Debjani Gagen; Mark S Filla; Tania N Crotti; Donna M Peters
Journal:  Biochim Biophys Acta       Date:  2013-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.